Castle Rock Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Castle Rock Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $483,911 - $570,659	-2,581 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$207.02 - $241.31 $49,891 - $58,155	241 Added 10.3%	2,581 $557,000
Q4 2020 Jan 29, 2021	BUY	$207.01 - $276.09 $102,469 - $136,664	495 Added 26.83%	2,340 $556,000
Q3 2020 Dec 07, 2020	BUY	$255.65 - $303.1 $83,853 - $99,416	328 Added 21.62%	1,845 $390,000
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $82,976 - $108,854	368 Added 32.03%	1,517 $418,000
Q1 2020 May 18, 2020	BUY	$199.77 - $247.81 $229,535 - $284,733	1,149 New	1,149 $318,000

1,725

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.